FDA Warns 61 Retailers for Unauthorized E-cigarette Sales in USA

Mar.27.2024
FDA Warns 61 Retailers for Unauthorized E-cigarette Sales in USA
FDA Issues Warnings to 61 Retailers Selling Unauthorized E-Cigarette Products, including popular brands among teenagers.

According to a statement from the U.S. Food and Drug Administration (FDA) on March 26th, the FDA has issued warning letters to 61 retail entities for selling unauthorized e-cigarette products. The warning letters specifically mention the sale of disposable e-cigarette products under the Elf Bar/EB Design and Lava brands.


The FDA stated that these warning letters are the result of long-term monitoring of multiple surveillance systems and their findings, with the aim of identifying products commonly used or popular among adolescents. Research results from the 2023 national youth tobacco survey showed that over 50% of adolescent e-cigarette users reported using the Elf Bar brand; in 2023, the manufacturer of Elf Bar began marketing their products under the name "EB Design". Furthermore, after reviewing retail sales data and recent youth survey data, the FDA has identified the Lava brand as popular among adolescents.


These retailers who received warning letters are selling or distributing e-cigarette products in the United States without FDA authorization, which violates the Federal Food, Drug, and Cosmetic Act. The recipients of the warning letters have been given 15 business days to respond, correct the violations, and prevent future violations. Failure to promptly correct the violations may result in the FDA taking further action, such as injunctions, seizure, and/or civil penalties.


These warning letters are part of the FDA's ongoing efforts to address the marketing and sales of unauthorized e-cigarettes targeting youth, including previous warning letters sent to online retailers selling similar unauthorized e-cigarettes.


So far, the FDA has issued more than 550 warning letters to retailers selling unauthorized e-cigarettes and has taken over 100 civil penalty actions.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.